# Antihypertensive Treatment of Acute Cerebral Hemorrhage-II

> **NCT01176565** · PHASE3 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 1000 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Intravenous nicardipine hydrochloride

## Key facts

- **NCT ID:** NCT01176565
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05-15
- **Primary completion:** 2015-12-21
- **Final completion:** 2016-03-08
- **Target enrollment:** 1000 (ACTUAL)
- **Why stopped:** Planned interim analysis: no significant outcome differences between groups
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176565, "Antihypertensive Treatment of Acute Cerebral Hemorrhage-II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01176565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*